Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression

Part of paid clinical trials in Worcester, Massachusetts.

Sponsor
Anebulo Pharmaceuticals
Study ID
NCT06017622
Status
Recruiting
Apply to this trial

Conditions

  • Acute Cannabis-induced CNS Depression

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This observational study is being conducted to determine plasma concentrations of tetrahydrocannabinol (THC) and its metabolites, 11-OH-THC and THC-COOH, in plasma of pediatric patients who visit the emergency department due to acute cannabis-induced CNS depression.

Key Dates

First listed
Aug 30, 2023
Start date
Jun 1, 2023
Status verified
Feb 2026
Primary completion
Dec 30, 2026
Completion
Dec 30, 2026

Study Design

Enrollment
36 participants (estimated)

Arms

  • Arm: All subjects
    There is a single group consisting of all subjects who meet the eligibility criteria

Primary Outcome Measure

Plasma Concentration of delta-9 tetrahydrocannabinol (THC) [ Time Frame: Day 1 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Massachusetts Memorial Children's Medical CenterWorcesterMassachusetts01605
Zachary W. Binder, MD
[email protected]
508-334-6090

Find similar trials in Worcester, MA

By research site
University of Massachusetts Memorial Children's Medical Center· Worcester, MA